Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea
Open Access
- 1 January 2016
- journal article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 31 (10) , 1579-1585
Abstract
Lim Y, et al. J Korean Med Sci. 2016 Oct;31(10):1579-1585. https://doi.org/10.3346/jkms.2016.31.10.1579Keywords
This publication has 19 references indexed in Scilit:
- Somatic Mutations of Calreticulin in Myeloproliferative NeoplasmsNew England Journal of Medicine, 2013
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for MyelofibrosisNew England Journal of Medicine, 2012
- Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008The Korean Journal of Hematology, 2012
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE projectBlood, 2010
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programsBlood, 2008
- Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithmsLeukemia, 2007
- Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panelBlood, 2007
- Epidemiology of the Myeloproliferative Disorders Polycythemia Vera and Essential ThrombocythemiaSeminars in Thrombosis and Hemostasis, 2006
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- Nationwide Cancer Incidence in Korea, 1999~2001; First Result Using the National Cancer Incidence DatabaseCancer Research and Treatment, 2005